Next Article in Journal
Milk Fermented by Specific Lactobacillus Strains Regulates the Serum Levels of IL-6, TNF-α and IL-10 Cytokines in a LPS-Stimulated Murine Model
Previous Article in Journal
Taurine Supplementation Alleviates Puromycin Aminonucleoside Damage by Modulating Endoplasmic Reticulum Stress and Mitochondrial-Related Apoptosis in Rat Kidney
Letter published on 6 January 2019, see Nutrients 2019, 11(1), 103.
Correction published on 22 March 2019, see Nutrients 2019, 11(3), 680.
Open AccessArticle

Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants

1
CIC Pédiatrique 1401 CHU, 33000 Bordeaux, France
2
ITERG, Université de Bordeaux, 33076 Bordeaux, France
3
Nestlé Health Sciences, 1066 Epalinges, Switzerland
4
Nestlé Research Centre, 1000 Lausanne, Switzerland
5
Nestlé Nutrition R&D, 1800 Vevey, Switzerland
6
Department of Neonatology, University of Liège, 4000 Liège, Belgium
7
Hôpital de la Croix Rousse, Hospices Civils, 69004 Lyon, France
8
Hôpital Clocheville, CHU de Tours, 37004 Tours, France
*
Author to whom correspondence should be addressed.
Nutrients 2018, 10(6), 690; https://doi.org/10.3390/nu10060690
Received: 27 February 2018 / Revised: 17 May 2018 / Accepted: 25 May 2018 / Published: 29 May 2018
Preterm infants require fortification of human milk (HM) with essential fatty acids (FA) to ensure adequate post-natal development. As part of a larger randomized controlled study, we investigated FA metabolism in a subset of 47 clinically stable preterm infants (birth weight ≤1500 g or gestational age ≤32 weeks). Infants were randomized to receive HM supplemented with either a new HM fortifier (nHMF; n = 26) containing 12.5 g medium-chain FA (MCFA), 958 mg linoleic acid (LA), 417 mg α-linolenic acid (ALA), and 157 mg docosahexaenoic acid (DHA) per 100 g of powder (in compliance with the latest guidelines) or a fat-free HMF (cHMF; n = 21). Plasma phospholipid (PL) and triacylglycerol (TAG), and red blood cell phosphatidylcholine (RBC-PC) and phosphatidylethanolamine (RBC-PE) FA profiles were assessed before and after 21 days of feeding. In the nHMF group, significantly increased levels of n-9 monounsaturated fatty acids were observed, formed most likely by elongation and desaturation of dietary saturated fatty acids present in HM. ALA fortification increased ALA assimilation into plasma TAG. Similarly, DHA fortification enriched the DHA content in RBC-PE, which, in this compartment, was not associated with lower arachidonic acid levels as observed in plasma TAG and phospholipids. RBC-PE, a reliable indicator of FA metabolism and accretion, was the most sensitive compartment in this study. View Full-Text
Keywords: arachidonic acid; docosahexaenoic acid; fatty acid metabolism; medium-chain fatty acids; preterm infants arachidonic acid; docosahexaenoic acid; fatty acid metabolism; medium-chain fatty acids; preterm infants
Show Figures

Figure 1

MDPI and ACS Style

Billeaud, C.; Boué-Vaysse, C.; Couëdelo, L.; Steenhout, P.; Jaeger, J.; Cruz-Hernandez, C.; Ameye, L.; Rigo, J.; Picaud, J.-C.; Saliba, E.; Hays, N.P.; Destaillats, F. Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants. Nutrients 2018, 10, 690.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop